{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T11:26:40Z","timestamp":1761564400652,"version":"build-2065373602"},"reference-count":26,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100008457","name":"University of Virginia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008457","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006492","name":"Division of Intramural Research, National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006492","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","npjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal for Nurse Practitioners"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.nurpra.2022.11.015","type":"journal-article","created":{"date-parts":[[2023,1,27]],"date-time":"2023-01-27T19:21:08Z","timestamp":1674847268000},"page":"104505","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Cases of Loiasis Among a Congolese Family: Screening for Loiasis Among Newly Arrived Refugees From Endemic Areas"],"prefix":"10.1016","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5371-4910","authenticated-orcid":false,"given":"Shalini","family":"Subbarao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reagan","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amy","family":"Klion","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fern R.","family":"Hauck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tania A.","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.nurpra.2022.11.015_bib1","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0001210","article-title":"The geographic distribution of Loa loa in Africa: results of large-scale implementation of the Rapid Assessment Procedure for Loiasis (RAPLOA)","volume":"5","author":"Zour\u00e9","year":"2011","journal-title":"PLoS neglected tropical diseases"},{"issue":"4","key":"10.1016\/j.nurpra.2022.11.015_bib2","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/S1473-3099(13)70263-9","article-title":"Loa loa\u2014does it deserve to be neglected?","volume":"14","author":"Metzger","year":"2014","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"10.1016\/j.nurpra.2022.11.015_bib3","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/S1473-3099(16)30405-4","article-title":"Excess mortality associated with loiasis: a retrospective population-based cohort study","volume":"17","author":"Chesnais","year":"2017","journal-title":"Lancet Infect Dis"},{"issue":"7","key":"10.1016\/j.nurpra.2022.11.015_bib4","doi-asserted-by":"crossref","first-page":"e1624","DOI":"10.1093\/cid\/ciaa1365","article-title":"A\u00a0randomized, placebo-controlled, double-blind pilot study of single-dose humanized anti-IL5 antibody (reslizumab) for the reduction of eosinophilia following diethylcarbamazine treatment of Loa loa infection","volume":"73","author":"Legrand","year":"2021","journal-title":"Clin Infect Dis"},{"issue":"11","key":"10.1016\/j.nurpra.2022.11.015_bib5","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1016\/S1473-3099(20)30256-5","article-title":"Burden of disease in Gabon caused by loiasis: a cross-sectional survey","volume":"20","author":"Veletzky","year":"2020","journal-title":"Lancet Infect Dis"},{"issue":"6","key":"10.1016\/j.nurpra.2022.11.015_bib6","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.4269\/ajtmh.2009.09-0356","article-title":"Loa loa microfilarial periodicity in ivermectin-treated patients: comparison between those developing and those free of serious adverse events","volume":"81","author":"Kamgno","year":"2009","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.nurpra.2022.11.015_bib7","series-title":"Loa loa (Cobbold 1864). Parasitic Diseases","first-page":"53","author":"Despommier","year":"1995"},{"issue":"3","key":"10.1016\/j.nurpra.2022.11.015_bib8","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/j.1708-8305.2012.00612.x","article-title":"Transient facial swellings in a patient with a remote African travel history","volume":"19","author":"Richardson","year":"2012","journal-title":"J\u00a0Travel Med"},{"issue":"7","key":"10.1016\/j.nurpra.2022.11.015_bib9","doi-asserted-by":"crossref","first-page":"2298","DOI":"10.1128\/JCM.00490-08","article-title":"Rapid, novel, specific, high-throughput assay for diagnosis of Loa loa infection","volume":"46","author":"Burbelo","year":"2008","journal-title":"J\u00a0Clin Microbiol"},{"issue":"8","key":"10.1016\/j.nurpra.2022.11.015_bib11","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0001299","article-title":"Rapid molecular assays for specific detection and quantitation of Loa loa microfilaremia","volume":"5","author":"Fink","year":"2011","journal-title":"PLoS Negl Trop Dis"},{"issue":"3","key":"10.1016\/j.nurpra.2022.11.015_bib13","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1086\/499238","article-title":"Diagnostic evaluation of newly arrived asymptomatic refugees with eosinophilia","volume":"42","author":"Seybolt","year":"2006","journal-title":"Clin Infect Dis"},{"issue":"suppl 1","key":"10.1016\/j.nurpra.2022.11.015_bib14","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1186\/1475-2883-2-S1-S7","article-title":"Loa loa encephalopathy temporally related to ivermectin administration reported from onchocerciasis mass treatment programs from 1989 to 2001: implications for the future","volume":"2","author":"Twum-Danso","year":"2003","journal-title":"Filaria J"},{"issue":"3","key":"10.1016\/j.nurpra.2022.11.015_bib15","doi-asserted-by":"crossref","first-page":"529","DOI":"10.4269\/ajtmh.1985.34.529","article-title":"The Mazzotti reaction following treatment of onchocerciasis with diethylcarbamazine: clinical severity as a function of infection intensity","volume":"34","author":"Francis","year":"1985","journal-title":"Am J Trop Med Hyg"},{"issue":"1","key":"10.1016\/j.nurpra.2022.11.015_bib16","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1093\/infdis\/168.1.202","article-title":"Albendazole in human loiasis: results of a double-blind, placebo-controlled trial","volume":"168","author":"Klion","year":"1993","journal-title":"J\u00a0Infect Dis"},{"issue":"3","key":"10.1016\/j.nurpra.2022.11.015_bib17","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1086\/598654","article-title":"Albendazole therapy for loiasis refractory to diethylcarbamazine treatment","volume":"29","author":"Klion","year":"1999","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.nurpra.2022.11.015_bib18","doi-asserted-by":"crossref","first-page":"100582","DOI":"10.1016\/j.eclinm.2020.100582","article-title":"Individual risk of post-ivermectin serious adverse events in subjects infected with Loa loa","volume":"28","author":"Chesnais","year":"2020","journal-title":"EClinicalMedicine"},{"issue":"9070","key":"10.1016\/j.nurpra.2022.11.015_bib19","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/S0140-6736(96)11094-1","article-title":"Serious reactions after mass treatment of onchocerciasis with ivermectin in an area endemic for Loa loa infection","volume":"350","author":"Gardon","year":"1997","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.nurpra.2022.11.015_bib20","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.parepi.2017.05.001","article-title":"Rapid integrated clinical survey to determine prevalence and co-distribution patterns of lymphatic filariasis and onchocerciasis in a Loa loa co-endemic area: the Angolan experience","volume":"2","author":"Brito","year":"2017","journal-title":"Parasite epidemiology and control"},{"issue":"6","key":"10.1016\/j.nurpra.2022.11.015_bib22","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.4269\/ajtmh.17-0337","article-title":"Absence of Loa loa microfilaremia among newly arrived Congolese refugees in Texas","volume":"97","author":"Montour","year":"2017","journal-title":"Am J Trop Med Hyg"},{"issue":"3","key":"10.1016\/j.nurpra.2022.11.015_bib23","doi-asserted-by":"crossref","first-page":"425","DOI":"10.4269\/ajtmh.2009.80.425","article-title":"Community based parasitic screening and treatment of Sudanese refugees: application and assessment of Centers for Disease Control guidelines","volume":"80","author":"Brodine","year":"2009","journal-title":"Am J Trop Med Hyg"},{"issue":"1","key":"10.1016\/j.nurpra.2022.11.015_bib24","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1093\/cid\/ciu723","article-title":"Eosinophil-associated processes underlie differences in clinical presentation of loiasis between temporary residents and those indigenous to loa-endemic areas","volume":"60","author":"Herrick","year":"2015","journal-title":"Clin Infect Dis"},{"issue":"11","key":"10.1016\/j.nurpra.2022.11.015_bib25","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1093\/cid\/ciz647","article-title":"Projected number of people with onchocerciasis-loiasis coinfection in Africa, 1995 to 2025","volume":"70","author":"Vinkeles-Melchers","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.nurpra.2022.11.015_bib26","doi-asserted-by":"crossref","DOI":"10.1186\/1756-3305-7-325","article-title":"The geographic distribution of onchocerciasis in the 20 participating countries of the African Programme for Onchocerciasis Control: (1) priority areas for ivermectin treatment","volume":"7","author":"Noma","year":"2014","journal-title":"Parasit Vectors"},{"issue":"8","key":"10.1016\/j.nurpra.2022.11.015_bib27","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0071574","article-title":"Mapping, bayesian geostatistical analysis and spatial prediction of lymphatic filariasis prevalence in Africa","volume":"8","author":"Slater","year":"2013","journal-title":"PloS One"},{"issue":"7","key":"10.1016\/j.nurpra.2022.11.015_bib28","doi-asserted-by":"crossref","first-page":"e2288","DOI":"10.1371\/journal.pntd.0002288","article-title":"Strongyloides stercoralis: global distribution and risk factors","volume":"7","author":"Sch\u00e4r","year":"2013","journal-title":"PLoS Negl Trop Dis"},{"issue":"2","key":"10.1016\/j.nurpra.2022.11.015_bib29","first-page":"103","article-title":"Clinical and laboratory features of patients with loiasis (Loa loa filariasis) in the U.K","volume":"33","author":"Churchill","year":"1996","journal-title":"J\u00a0Infect"}],"container-title":["The Journal for Nurse Practitioners"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1555415522004822?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1555415522004822?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T10:33:41Z","timestamp":1761561221000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1555415522004822"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":26,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["S1555415522004822"],"URL":"https:\/\/doi.org\/10.1016\/j.nurpra.2022.11.015","relation":{},"ISSN":["1555-4155"],"issn-type":[{"type":"print","value":"1555-4155"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cases of Loiasis Among a Congolese Family: Screening for Loiasis Among Newly Arrived Refugees From Endemic Areas","name":"articletitle","label":"Article Title"},{"value":"The Journal for Nurse Practitioners","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nurpra.2022.11.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"104505"}}